CDHR5 and familial pancreatic carcinoma: In our study, we also analysis CDHR5 expression in pancreatic adenosquamous carcinoma in the TMA, outcomes suggested that CDHR5 was down‐regulated in this pancreatic cancer subtype, which was different from that in PDAC (data not shown).